Topic
Dermatology Research
Topic counter · /dermatology research
Dermatology Research
1 piece on this counter
· 2 min
FDA Clears Phase 2a Trial of Dual-Target Antibody NAV-240 for HS
Navigator Medicines has begun dosing patients in an FDA-cleared phase 2a trial of NAV-240, a dual-target antibody blocking TNF and O40L in moderate to severe H…
